Sentence examples for a particular end point from inspiring English sources

Any fibers considered inactive for a particular end point and why.

TEF values are an order of magnitude estimate of the overall "toxic potency" of a given compound and therefore do not specifically refer to the potency from any single study with a particular end point.

The bioassay-directed fractiontion and identification methodology used to identify CECs can be linked to a particular end point (Gracia et al. 2008), such as mortality, or to a specific biochemical effect, such as estrogenicity (Snyder et al. 2000).

Probabilistic approaches are facilitated by defining the risk of a given end point in terms of population risk, such as the predicted number of cases for a particular end point.

Cancer researchers, clinicians, and patients are increasingly interested in nomograms which are defined as a graphical representation of a statistical model to predict a particular end point according to the individual characteristics of a patient (Isariyawongse and Kattan, 2012).

It can also be helpful to define the risk of a particular end point in respect to only those individuals who are at the high end of the exposure distribution (e.g., living at the fence line of a point source) or to those individuals who will incur the greatest increased risk (e.g., children who are more biologically susceptible because of age or size).

The practice has distinct benefits -- otherwise it would be pretty silly to bother -- but there's no particular end point.

Therefore, a board of experts from German committees in charge of the derivation of OELs discussed the major challenges of this particular end point for regulatory toxicology.

The hormetic dose-response range was generally limited to about one order of magnitude, with the upper end of the hormetic curve approaching the estimated no observable effect level for the particular end point.

Clinical trial design and end points John Smyth, Ian Judson, Duncan Jodrell and Pat Price Early clinical trial design has developed dramatically over the past 20 years, and in particular, end points in Phase I trials have changed from toxicity to pharmacodynamics.

This is said to be a holiday test, and it does not have a particular end date at this point.